 |
Robert J. Paradiso is an Intellectual Property Attorney in the Tech Group and leads the firm’s life sciences patent practice. He assists domestic and international corporations, as well as higher learning institutions, on virtually all aspects of intellectual property, including the drafting and prosecution of patent applications. Mr. Paradiso also counsels on matters related to non-infringement, patentability, litigation, due diligence, freedom to operate, licensing and technology transfer.
Mr. Paradiso has strategically built extensive patent portfolios across a myriad of disciplines, obtaining patents for his clients in areas including pharmaceutical formulations, new chemical entities, combination therapies, chemical processes, medical treatments, inhalation and intranasal therapies, biotechnology, and medical and mechanical devices. In this capacity, Mr. Paradiso works closely with both scientists and in-house counsels during all phases of research and development from initial synthesis, through formulation and clinical trials, and during regulatory review. He also provides expertise in the development of lifecycle management, marketing and business strategies.
Mr. Paradiso has represented innovators and generic and specialty pharmaceutical companies with respect to patent issues related to NDA, ANDA and §505(b)(2) filings with the U.S. Food and Drug Administration under the Hatch-Waxman Act. He has successfully obtained patents that have been listed in the FDA Orange Book for NDA approved drug products and has counseled clients with respect to Paragraph IV Certifications.
Prior to joining Lowenstein Sandler, Mr. Paradiso practiced law as a Partner with an Intellectual Property boutique in New York City.
Mr. Paradiso is a registered pharmacist in New York and New Jersey.
Recent Speaking Engagements:
- "Patent Reform, Resolutions & Additional Rulings--Interpretations, Impacts and Strategies for the Challenges Ahead," panelist, PharmaBiotech IP Summit, May 29, 2008
- "Developing Intellectual Property," panelist, Growing the Next Generation of Green Ventures Sustainable Entrepreneurship Symposium and Expo, May 2, 2008
- "Patents and Innovation," presenter, Susquehanna Financial Group SIGnificant Investment Options in Healthcare, March 4, 2008
|
Robert J. Paradiso spotlighted as a contributor for his insights on intellectual property rights and claims that have arisen as a result of the human genome project.,
RegentAtlantic Capital, LLC, December 2007
|
|
Robert J. Paradiso comments on the Patent Reform Act of 2007 and key concerns among biotechnology companies.,
NJBiz, September 13, 2007
|
|
|
 |
St. John's University School of Law
(J.D., 1994)
|
|
Long Island University
(B.S., 1990),
Pharmacy
|
|
New York
|
|
New Jersey
|
|
United States Patent and Trademark Office
|
| |